Introduction The composition of plasma and Cerebrospinal fluid (CSF) are similar with the only major difference between the two being the greatly reduced.

Slides:



Advertisements
Similar presentations
So how good are your results? (An introduction to quantitative QC)
Advertisements

AACB NSW/ACT QC Subcommittee TnT hs Survey Results Methods Results Introduction Persephone Giannopoulos¹ and representatives of the AACB NSW/ACT QC Subcommittee.
Use of BVBlue ® to Confirm Sialidase Contamination of Samples for ß2transferrin Determination. L Boscato Department of Chemical Pathology St Vincent’s.
Evaluation of the IMMY CrAg Lateral Flow Assay for Detection of Cryptococcal Antigen Susan Clarke and Robert Gibb Pathology Queensland – Central, Royal.
An epidemic in transition: impacts of migration and local networks on HIV sequence diversity and infection transmission in Australia
Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay K.K.Y. Lai, M. Jin,
“Diagnostic value of procalcitonin in well appearing young febrile infants” Pediatrics 2012; 130:
Use of avidity reagent. Panbio Buffered Avidity Reagent Mild protein-denaturing solution that may be useful in differentiating recent infections from.
The Importance of Commutability of Reference Materials Used as Calibrators: The Example of Ceruloplasmin I. Zegers, R. Beetham, T. Keller, J. Sheldon,
A Simple Protocol for Identification of Heterophile Antibody Interferences in the Abbott AxSYM hCG Assay. P Giannopoulos, G Jones, E-M Lim Department of.
PREOPERATIVE PLASMA CONCENTRATION OF MMP-9/TIMP-1 COMPLEXES IS NOT ASSOCIATED WITH DISEASE OUTCOME IN PRIMARY BREAST CANCER (N=483) Anne-Sofie Schrohl.
L MACKAY, N CRINIS, Q LAM, R SCOTT
MHA APCCB A SERUM INDEX FOR METHAEMALBUMIN: THE M-INDEX GRD Jones, M Roser, B Zworestine Department of Chemical Pathology, St Vincents Hospital,
Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.
Summary 1 l The Analytical Problem l Data Handling.
Kelley Bemis Use of automated testing in syphilis diagnosis and its impact on surveillance – Connecticut, 2010 CDC/CSTE Applied Epidemiology Fellowship.
BOHB APCCB LABORATORY USE OF THE ABBOTT MEDISENSE METER FOR BETA-HYDROXYBUTYRATE MEASUREMENT. GRD Jones, A Screnci, P Graham Chemical Pathology,
Diagnostic Assays to Plan Specific Drug Treatment Elizabeth Hammond MD.
Creatinine and the eGFR Graham Jones Department of Chemical Pathology St Vincent’s Hospital, Sydney AACB-AIMS Annual Scientific meeting Hobart 2006.
Clare Prohaska.   Placed at Royal Prince Alfred Hospital in Sydney, Australia  14 hour flight from LAX to SYD Australia.
APCCB AVERAGE OF DELTA – A NEW CONCEPT IN QUALITY CONTROL GRD Jones Department of Chemical Pathology, St Vincents Hospital, Sydney, Australia.
PG-Seph. APCCB IDENTIFICATION OF MACRO- PROLACTIN WITH PROTEIN-G SEPHAROSE Jones GRD, Giannopoulos P. Departments of Chemical Pathology, St Vincent’s.
Measurements for 8 Common Analytes in Native Sera Identify Inadequate Standardization among 6 Routine Laboratory Assays H.C.M. Stepman, U. Tiikkainen,
Introduction to Analytical Chemistry
SW & Wessex Regional Audit Laboratory Investigations of Chronic Diarrhoea Sue Bird. Clinical Pathology, Dorset County Hospital, DORCHESTER, Dorset Introduction.
Jaw Pain: Characteristics and Prevalence in Fibromyalgia and other Rheumatic Disorders Robert S. Katz 1, Frederick Wolfe 2. 1 Rush University Med Center,
Director of Scientific Affairs
Evaluation of Beckton-Dickinson PST II and SST II Blood Collection Tubes P Graham, B Martin, M Roser, G Jones Department of Chemical Pathology, St Vincent’s.
MEDICAL TESTING Doctor requires information Patient sample collection
Quality Control Lecture 5
Accuracy of 6 Routine 25-Hydroxyvitamin D assays; Influence of Vitamin D Binding Protein Concentration A.C. Heijboer, M.A. Blankenstein, I.P. Kema, and.
G Jones, M Roser Department of Chemical Pathology
BNPCV APCCB BIOLOGICAL VARIATION FOR N-TERMINAL PRO-BNP Jones GRD 1, Bennett A 2,3, Boscato L 1, Macdonald P 2, Brien J 3. Departments of Chemical.
From Genome-Wide Association Studies to Medicine Florian Schmitzberger - CS 374 – 4/28/2009 Stanford University Biomedical Informatics
Interferences - are some methods better than others? Graham Jones Department of Chemical Pathology St Vincent’s Hospital, Sydney.
Assay precision of the Beckman Coulter AMH GEN II enzyme linked immunosorbent assay (ELISA) assessed using commercial controls and pooled patient serum.
Queensland University of Technology CRICOS No J Health Complaints Commissions in Australia: Time for a National Approach to Data Collection Merrilyn.
Laboratory Careers Packet #4. Introduction Individuals working in this field have various tasks, duties, interests and abilities. Laboratory personnel.
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
Evaluation of the Presage™ ST2 ELISA Jun Lu 1, David G. Grenache 1,2 1 ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 2 Department.
Serum Levels of Glycosaminoglycans (GAGs) and Insulin Like Growth Factor-1 (IGF-1) as New Diagnostic Markers for Hepatocellular Carcinoma. Ahmad S. Ibrahim*,
Is avoidable mortality a good measure of the quality of hospital care? Dr Helen Hogan Clinical Senior Lecturer in Public Health London School of Hygiene.
Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.
Verification of qualitative methods
Introduction to Clinical Chemistry MLCC-203 Department of Medical Laboratory Technology Faculty of Allied Medical Science By Dr. Eman El-Attar.
Comparability of methods and analysers Nora Nikolac
Journal Club Optimizing Early Rule-Out Strategies for Acute Myocardial Infarction: Utility of 1-Hour Copeptin P. Hillinger, R. Twerenbold, C. Jaeger, K.
Journal club Diagnostic accuracy of Urinalysis for UTI in Infants
 The study of the composition, structure, and properties of matter and the changes it undergoes.
Overview of analytical chemistry Chemistry 321, Summer 2014.
Outcome of CSF Analysis in Babies with Elevated CRPs but Clinically Well Dr Charlotte Davidson, Dr David Deekollu Prince Charles Hospital, Cwm Taf University.
BioPlex 2200 HIV Ag-Ab Assay
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
RESEARCH POSTER PRESENTATION DESIGN © Cardiac Troponin Assay Cardiac troponin I is the diagnostic marker used for myocardial.
Which troponin assay to choose? Clinical performances of troponin T and troponin I assays Per Venge, MD PhD Professor Department of Medical Sciences Uppsala.
Troponin By Julie Moore C Dt204/2.
DIAGNOSIS OF WILSON’S DISEASE – A 20-YEAR AUDIT Geetha Rathnayake 1, Mirette Saad 2, Kay Weng Choy 1, James CG Doery 1,3 1 Monash Pathology, Monash Medical.
COMPLETENESS OF LABORATORY INVESTIGATION REQUEST FORMS BY DOCTORS
Estimated Glomerular Filtration Rate and Albuminuria Are Associated with Biomarkers of Cardiac Injury in a Population-Based Cohort Study: The Maastricht.
Measurement of oxygen saturation during exercise testing in pulmonary rehabilitation: a survey Leung R1, McKeough Z1, McDonald C2, Jenkins S3, Holland.
Fig. 2. Distribution of vitamin D levels of all samples by Siemens, Abbott, and DiaSorin. The mean (SD) of Siemens, Abbott, and DiaSorin assays was
PLASMA HOMOCYSTEINE LEVELS AS A PREDICTOR
BODY FLUIDS: Cerebrospinal Fluid (CSF)
MonashPathology MonashHealth
Table 2. Cerebrospinal Fluid Analysis (CSF analysis)
Correlation of platelet indices in various disease groups with thrombocytopenia Tapasyapreeti Mukhopadhyay, Rupali Awale, Ratnaprabha Maji, Subhadra Sharma,
MonashPathology 17-HYDROXYPROGESTERONE ASSAYS – TIME FOR HARMONISATION
ASSESSMENT OF GOLD NANOPARTICLE BASED CORTISOL STRIPS TO ASSIST CATHETERISATION DURING BILATERAL ADRENAL VEIN SAMPLING: A ROYAL NORTH SHORE PERSPECTIVE.
Meningitis Surveillance and investigation of causes of altered mental status among Kamuzu Central Hospital admissions, Lilongwe, Malawi Charles Kyriakos.
BODY FLUIDS: Cerebrospinal Fluid (CSF)
Presentation transcript:

Introduction The composition of plasma and Cerebrospinal fluid (CSF) are similar with the only major difference between the two being the greatly reduced concentration of total protein in CSF 1. The CSF is actively secreted by the four choroid plexuses and the concentration of some ions e.g. K+, are independent of the variations in the plasma concentration. CSF total protein levels are often used to support a diagnosis. Elevated levels of CSF total protein are suggestive of bacterial infection 2. Suspected meningitis / meningoencephalitis requires urgent CSF examination. It has been stated that CSF total protein determination should only be used as a screening test for meningitis 3. Method (continued) ResultsResults (continued) AACB CSF Working Party Investigation of CSF Total Protein Result Variation. G.I. Raines 1, G. Whittaker 2, M. Jenkins 3, S. Tran 4, G. Kellerman 4, M. Clough 5, J. Gill 6, S. Jovanovich 6, T. Andersen 7, D.A. Berry 8. 1 Clinical Biochemistry Unit, The Alfred, Melbourne,Vic.3004, Australia; 2 Biochemistry, Royal Prince Alfred Hospital, Sydney, Australia; 3 Biochemistry Department, Austin Pathology, Austin Health, Heidelberg VIC., Australia; 4 Clinical Chemistry, Hunter Area Pathology Service, Newcastle, NSW, Australia; 5 Clinical Chemistry, ICPMR, Westmead Hospital, Westmead, NSW, Australia; 6 RCPA-AACB Quality Assurance Programs Pty Limited, Bedford Park, SA, Australia; 7 Australian Scientific Enterprise, Sydney, Australia; 8 SEALS Sutherland Centre of Immunology, Sutherland Hospital, Caringbah, NSW, Australia. Aim The aim of the CSF working party is to improve the quality of the analytical performance of the CSF total protein assay. CSF total protein results from the RCPA QAP show distinct assay groups. The CSF Working Party conducted a survey of patient CSF samples to determine the cause of this variation in the assay results. Method Three laboratories distributed twelve unfrozen patient CSF samples. The following analysers were used: Roche Modular PPE- Lab A; Abbott Laboratories Architect ci8200- Lab B; Beckman Coulter DXC 800- Lab C; Ortho-Clinical Diagnostics Vitros Fusion 5.1- Lab D and Siemens Dimension RXL Max- Lab E. Table 1 lists the analysers, reagent and methods used in the study. They form the distinct total protein groups identified in the RCPA QAP program. Table 1. Summary of Analysers and Methods. Conclusion Patient CSF total protein results showed the same pattern of variability as seen in the RCPA CSF QAP samples. Since a ratio was used we conclude that there is no matrix effect contributing to the variation seen in the RCPA QAP reports. Thus the groups of results can be contributed to calibration or method variation and more standardisation of assays is required to improve comparability between laboratories. The procedures and methods for determination of CSF total protein are incompletely standardised and this is reflected in the lack of agreement between laboratories. Results of routine CSF total protein analysis is not disease specific. The interpretation of the results should take into account the sensitivity and specificity limitation. References 1.Brown P.D. et al. Neuroscience. 129(4) 2004: Daroriche R.O. et al. N Engl J Med. 355(19) 2006: Franciotta D. et al. Journal of Neurological Sciences : Table 2. Summary of Calibration Material used in CSF total protein Analysis. Figure 1 Graph of RCPA QAP CSF Samples vs. CSF TP (g/l) Figure 2 Graph of Patient CSF Samples vs. CSF TP (g/l) Patient CSF samples 3, 8 and 9 were haemolysed. The mean of Lab A and Lab B results were used and a ratio was determined between this mean and the results of the other three labs. The ratio for the RCPA QAP for Lab C = 1.09; Lab D = 1.37; Lab E =1.19. The ratio for the patient CSF samples for Lab C = 1.09; Lab D = 1.37; Lab E =1.14. Table 3 Summary of the Total Protein results in g/L The following graphs summarise the results of the RCPA QAP and patient CSF samples Lab E was not able to assay four patient samples (indicated by green arrows in Fig 2).